Endometrial Neoplasms - 24 Studies Found
| Completed |
: Follow-up Care After Treatment for Endometrial Cancer : Endometrial Neoplasm : 2008-09-09 |
| Recruiting |
: The Role of Indocyanine Green to Identify Sentinel Lymph Node in Uterine Cancer : Endometrial Neoplasm : 2016-06-24 : Procedure: Sentinel lymph node mapping Before laparoscopic hysterectomy and lymphadenectomy procedure fo |
| Withdrawn |
: Lenvatinib in Second Line Endometrial Carcinoma : Endometrial Neoplasms : 2016-08-18 :
|
| Recruiting |
: Phase 2 Study of MLN0128, Combination of MLN0128 With MLN1117, Paclitaxel and Combination of MLN0128 With Paclitaxel in Women With Endometrial Cancer : Endometrial Neoplasms : 2016-03-28 :
|
| Completed |
: Studies of the Tumour Suppressor Gene PTEN - Endometrial Cancer : Endometrial Neoplasms : 2011-02-11 :
|
| Recruiting |
: Sentinel Lymph Node Detection in Endometrial Cancer : Endometrial Neoplasms : 2015-11-05 : Procedure: Sentinel node procedure Patients with Endometrial cancer undergo Sentinel node procedure usin |
| Recruiting |
: Indocyanine Green Versus Blue Dye for Detection of Sentinel Lymph Node In Endometrial Cancer : Endometrial Neoplasms : 2015-09-29 : Procedure: Sentinel lymph node biopsy |
| Active, not recruiting |
: The Feasibility Study of the Li Brush for the Screening of Endometrial Cancer in the Postmenopausal Period : Endometrial Neoplasms : 2015-07-08 |
| Completed |
: Diet and Physical Activity in Uterine Cancer Survivors : Endometrial Neoplasms : 2015-04-20 : Behavioral: Shape-Up following cancer treatment The programme is based on "Social Cognitive Theory& |
| Withdrawn |
: Ponatinib in the Treatment of FGFR Mutation Positive Recurrent or Persistent Endometrial Carcinoma : Endometrial Neoplasms : 2013-06-25 : Drug: Ponatinib Ponatinib 45 mg daily for 4 weeks (4 weeks equal one cycle) |